Biostar Pharm

Beijing Biostar Pharmaceuticals Co., Ltd. is a national high-tech enterprise focusing on the development of oncology products with independent intellectual property through state-of-the-art synthetic biology technology platforms. The company has developed Utidelone, a new-generation microtubule inhibitor, and has an extensive R&D pipeline.